FDA approves supplemental drug application for Pfizer’s EURCRISA in children with eczema

March 25, 2020
Research and Development, Sales and Marketing eczema, eczema cream, eczema ointment

Pfizer announced that the FDA has approved its supplemental New Drug Application for EUCRISA ointment in treating 3 month year …

microsoftteams-image_1

Eyeforpharma Barcelona 2020 is now a free virtual event

March 25, 2020
Medical Communications, Research and Development COVID-19, Eyeforpharma Barcelona 2020, coronavirus, events, eyeforpharma, pharma

In light of the rapidly evolving impact of the COVID-19 virus, eyeforpharma has decided to turn eyeforpharma Barcelona 2020 into …

30020836983_0c6d0e542e_b

Demand for hydroxychloroquine soars after Trump says it can treat coronavirus

March 25, 2020
Research and Development, Sales and Marketing COVID-19, Wuhan Coronavirus, china coronavirus, coronavirus, covid19

President Trump has continually touted the effectiveness of anti-malaria drug Hydroxychloroquine in treating coronavirus which has led to a jump …

partnership

AstraZeneca to leverage Silence Therapeutics’ siRNA expertise in $480mn deal

March 25, 2020
Research and Development, Sales and Marketing AstraZeneca, Silence Therapeutics, collaboration, pharma

Silence Therapeutics has revealed it has struck a new collaboration with AstraZeneca which will trigger the “acceleration and re-prioritisation of …

Roche shows improved survival rates in new treatment for untreated acute myeloid leukaemia

March 24, 2020
Manufacturing and Production Cancer, Roche, acute myeloid leukamia

Roche has announced that its clinical trials for Venclexta/Venclyzto combination with azacitidine have met its primary endpoints of overall survival …

screen_shot_2020-01-29_at_16

Sustainability and security: How packaging is modernising pharma

March 24, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing counterfeit medicines, falsified medicines, feature, packaging, pharma

In a world living in the shadow of substandard and falsified medicines, climate change and antimicrobial resistance, pharmaceutical packaging will …

Nanovax’s seasonal flu vaccine meets Phase 3 endpoints and matches Sanofi’s Fluzone

March 24, 2020
Manufacturing and Production, Research and Development NanoFlu, Nanovax, influenza, pharma

Nanovax has reported positive Phase 3 data for its vaccine NanoFlu, with the candidate meeting its primary endpoints in the …

China approves Takeda’s treatment for ulcerative colitis and Crohn’s disease

March 24, 2020
Manufacturing and Production Crohn's, Takeda, Takeda China

China’s National Medical Products Administration (NMPA) has approved Takeda’s Entyvio (vedolizumab) for the treatment of adult patients with ulcerative colitis …

30562517863_f4ff8e801a_b_1

UK begins lockdown as government announce tough measures to stop the spread of COVID-19

March 24, 2020
Manufacturing and Production COVID-19, Chinese Coronavirus, Wuhan Coronavirus, coronavirus, coronavirus pandemic, global pandemic

Last night, British Prime Minister Boris Johnson announced sweeping measures to bring Britain into a near total societal lockdown in …

fda2outsideweb

FDA turns down label expansion for Jardiance as an adjunct to insulin in type 1 diabetes

March 23, 2020
Sales and Marketing FDA, diabetes, jardiance, pharma

The FDA has chosen not to approve an expanded indication of 2.5mg Jardiance (empaglifozin) as an adjunct to insulin in …

27774208927_ec889a371c_b

More young coronavirus patients being hospitalised in Europe and US compared to China

March 23, 2020
Sales and Marketing COVID-19, Wuhan Coronavirus, china coronavirus, coronavirus

Dr Anthony Fauci, the Director of the National Institute of Allergy and Infectious Disease in the US, said that people …

landing-hero-images1

ViiV Healthcare scores world-first approval in Canada for monthly HIV regimen Cabenuva

March 23, 2020
Sales and Marketing Cabenuva, Canada, HIV, pharma

ViiV Healthcare has secured its first global approval for its once-monthly treatment Cabenuva, it has emerged, to replace current antiretroviral …

lung_cancer_on_chest_x-ray

AI may help predict patient response to non-small cell lung cancer therapies

March 23, 2020
Medical Communications, Sales and Marketing Cancer, Lesions, cancer treatment, tumour treatment

Researchers have used artificial intelligence to train algorithms to predict tumour sensitivity to systemic cancer therapies. Radiologists previously determined if …

7424861282_ee152c7c60_b

US continues sanctions against Iran despite coronavirus ravaging both nations

March 23, 2020
Manufacturing and Production, Sales and Marketing Iran, Iran US, US, coronavirus

The Trump administration is not relaxing sanctions on Iran, despite the country having one of the highest death tolls from …

california_state_flag

Los Angeles County and California State near lockdown after “safer-at-home” mandate is announced

March 20, 2020
Medical Communications Wuhan Coronavirus, china coronavirus, coronavirus

Last night, Los Angeles County, and later California State, announced a mandate to make people work and stay at home …

gilead-sciences

FDA greenlights Gilead’s Epclusa in hepatitis C patients over six years old

March 20, 2020
Medical Communications, Research and Development Epclusa, Gilead, pharma

Gilead’s Epclusa (sofosbuvir and velpatasvir) has been awarded new marketing approval from the FDA in the treatment of hepatitis C …

top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

March 20, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Wuhan Coronavirus, china coronavirus, coronavirus

The COVID-19 coronavirus continues to dominate the news: A flu drug has appeared to be effective in treating COVID-19 while …

europe-1395916_640

Drug launches across Europe will be affected by coronavirus

March 20, 2020
Medical Communications, Sales and Marketing EU, Europe, coronavirus, pharma

The COVID-19 pandemic will affect European launches of drugs for a host of diseases including HIV, cancer and sickle cell …

science_nhmrc-grant-annoucement_180824_-_pic_1

New findings on influenza could help improve cancer treatments

March 20, 2020
Manufacturing and Production, Medical Communications Cancer, cancer treatments, flu, flu treatments, influenza

A new study into how the body fights influenza could help improve cancer immunotherapies. Researchers at the Fox Chase Cancer …

The Gateway to Local Adoption Series

Latest content